PROCEPT BioRobotics CorporationPRCTNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank50
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-58.34M
↑ 24% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-76.59M
Historical baseline
PeriodValueYoY Change
2025$-58.34M+43.7%
2024$-103.62M+22.2%
2023$-133.21M-60.4%
2022$-83.03M-43.3%
2021$-57.93M-19.2%
2020$-48.58M+5.5%
2019$-51.43M-